About Contact Us Careers
Sign In

Cancer Vaccines Market Size

  • Report ID: 2402
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Cancer Vaccines Market Size

Cancer Vaccines Market size was valued at USD 9.36 billion in 2023 and is set to exceed USD 38.99 billion by 2036, registering over 11.6% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of cancer vaccines is evaluated at USD 10.23 billion.

Cancer Vaccines Market Graph
Get more information on this report: Request Free Sample PDF
Browse Key Market Insights with Data Illustration:

Author Credits:  Radhika Pawar


  • Report ID: 2402
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising cases of cancer and increased demand for cancer vaccines as an alternate treatment method with lesser side effects are the major growth driving factors for the market.

The market is anticipated to attain a CAGR of 17.5% over the forecast period, i.e. 2020-2028.

The market in Asia Pacific is projected to provide more business opportunities as a result of rising cases of cancer in the region and growing presence of leading pharmaceutical and biotechnology companies.

The major players in the market are AstraZeneca, Bristol-Myers Squibb Company, GlaxoSmithKline plc., Sanofi, Merck & Co Inc, Astellas Pharma Inc., VBI Vaccines Inc., Moderna, Inc., Advaxis Immunotherapies and Galena Biopharma.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample